Position history for CITADEL ADVISORS LLC's holdings in AN2 THERAPEUTICS INC
CITADEL ADVISORS LLC holds 155,239 shares of ANTX (AN2 THERAPEUTICS INC), worth $530,917 as of 2026-Q1. The position was increased (+34.4% shares). ANTX represents 0.0% of CITADEL ADVISORS LLC's portfolio.
Current Value
$530,917
Current Shares
155,239
Total Value Change
-$2.8M
Total Shares Change
-1.4M
Other major holders of ANTX: RA CAPITAL MANAGEMENT, L.P.
Increased |
| 155,239 |
+34.4% |
| $530,917 |
| 0.0% |
| $1.06 |
31 |
| 2025-Q4 | Increased | 115,536 | +402.1% | $131,711 | 0.0% | $1.08 | 24 |
| 2025-Q3 | Increased | 23,013 | +84.2% | $29,227 | 0.0% | $1.28 | 21 |
| 2025-Q2 | New | 12,497 | - | $13,247 | 0.0% | $1.08 | 27 |
| 2025-Q1 | Exited | 0 | -100.0% | $0 | 0.0% | $1.39 | 0 |
| 2024-Q4 | New | 67,994 | - | $93,832 | 0.0% | $1.41 | 33 |
| 2024-Q3 | Exited | 0 | -100.0% | $0 | 0.0% | $1.06 | 0 |
| 2024-Q2 | Decreased | 1.6M | -0.2% | $3.3M | 0.0% | $2.15 | 0 |